Biogen Pharmachem Ltd is in the business of trading in shares and securities in present and future market.Business Overview: Company used to deal in shares and securities and traded in commodities including agro based and precious metals and other goods in present and future markets
Biogen Pharmachem Industries has confirmed no deviation in the utilization of funds raised from its Preferential Issue. The company secured Rs 25 Crore on April 15, 2025, explicitly for business expansion and general corporate purposes. As of June 30, 2025, the entire Rs 25 Crore has been utilized precisely as...
Biogen Pharmachem Industries Limited has announced the Annual Secretarial Compliance Report for the financial year 2024-25, prepared by KH & Associates, Practicing Company Secretaries. The report confirms full compliance with applicable SEBI regulations and circulars, with no violations or actions taken by SEBI or stock exchanges against the company or...
